ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinal stromal tumors - Æxlishemjandi lyf - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
amlodipine vitabalans tafla 10 mg
vitabalans oy - amlodipinum besýlat - tafla - 10 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
amlodipine vitabalans tafla 5 mg
vitabalans oy - amlodipinum besýlat - tafla - 5 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandimmun innrennslisþykkni, lausn 50 mg/ml
novartis healthcare a/s - ciclosporinum inn - innrennslisþykkni, lausn - 50 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sporimune vet. (sporimune) mixtúra, lausn 50 mg/ml
le vet beheer b.v. - ciclosporinum inn - mixtúra, lausn - 50 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandimmun neoral mixtúra, lausn 100 mg/ml
novartis healthcare a/s - ciclosporinum inn - mixtúra, lausn - 100 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandimmun neoral mjúkt hylki 100 mg
novartis healthcare a/s - ciclosporinum inn - mjúkt hylki - 100 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandimmun neoral mjúkt hylki 25 mg
novartis healthcare a/s - ciclosporinum inn - mjúkt hylki - 25 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandimmun neoral mjúkt hylki 50 mg
novartis healthcare a/s - ciclosporinum inn - mjúkt hylki - 50 mg
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
verkazia
santen oy - ciclosporin - conjunctivitis; keratitis - augnlækningar - meðferð alvarlega vernal keratoconjunctivitis (vkc) í börn frá 4 ára aldri og unglingar.